BridgeBio Pharma (BBIO) PT Raised to $102 at Wells Fargo

August 11, 2026 6:57 AM

Wells Fargo analyst Derek Archila raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $102.00 (from $98.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found